Project Grant R01DK122603

Federal Grant Award Summary The Jaeb Center for Health Research Foundation, Inc. received a $2.34 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 3, 2025, with completion scheduled for August 31, 2028. The project, titled "Care Partner-Assisted Implementation of Patch Hybrid Closed Loop Insulin Delivery for Older Adults...

Federal Cooperative Agreement Summary The University of California, San Diego received a $2.26 million Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 11, 2025, with completion scheduled for August 31, 2028. The award funds a clinical research initiative to evaluate the safe use of sodium-glucose cotransporter inhibitors...

Federal Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $780,220 Project Grant awarded on February 27, 2026, by the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds a clinical optimization trial to develop and evaluate a scalable digital behavioral intervention for mitigating level 2 hypoglycemia (severe...

This National Science Foundation (NSF) Division of Social and Economic Science Project Grant awarded to Emory University for $231,685 examines how different organizations, such as medical clinics, technology companies, and schools, influence access to and use of medical devices for youth with diabetes. The two-phased project focuses on continuous glucose monitoring (CGM) devices and insulin pumps, investigating how these organizations and their interactions shape health inequities in the use...

Cooperative Agreement Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Melbourne a $987,196 Cooperative Agreement on September 12, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a randomized-controlled clinical research study evaluating optimal ketone response thresholds for individuals with type 1 diabetes. The research addresses a critical safety concern limiting the...

This $1.2 million project grant from the National Science Foundation's Engineering program (CFDA 47.041) will fund research at Stanford University from September 2022 to August 2026 to develop digital tools and algorithms to improve diabetes care delivery and health equity. Specifically, the university will leverage sensor data and machine learning techniques to better understand patient types and needs, allocate limited provider resources efficiently, and design interpretable treatment...

This National Science Foundation (NSF) Division of Computer and Network Systems Project Grant award totaling $839,998 to Michigan State University supports the development of a novel wireless optoelectronic implant system for closed-loop control of bi-hormone (insulin and glucagon) secretion from genetically modified islet organoids. The goal is to create an implantable, wireless, and battery-free device that can precisely regulate hormone levels to manage type 1 diabetes. The project involves...

Federal Grant Award Summary The University of Virginia received a $788,831 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 1, 2026, with a completion date of December 31, 2029. The award funds the development of a ketone-aware automated insulin delivery (AID) system designed to enable safe use of sodium-glucose cotransporter inhibitors...

Federal Cooperative Agreement Summary AdventHealth Orlando has been awarded $7.43 million through a Cooperative Agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 11, 2025, with completion targeted for August 31, 2028, funds the KARMA (Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2...

Federal Cooperative Agreement Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Cooperative Agreement totaling $194,654 to The Royal Institution For The Advancement Of Learning (McGill University) on September 10, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, "Continuous Ketone Monitoring with the Use of SGLT2 Inhibitors in T1D," is led by Principal Investigator...